Professor Steven Kelly
Professor of Microbial Genetics and Molecular Biology
Professor Steven Kelly was born in Cardiff and studied in the newly founded Genetics Department in Swansea until 1983 undertaking his BSc and a PhD involving yeast genetics. He learned yeast genetic engineering with Paul Nurse and gained a Lectureship in Sheffield University Krebs Institute, moving to a Chair at Aberystwyth in 1997 where he was lead for molecular biology and Director of the Wolfson Laboratory of Cytochrome P450 Biodiversity. In 2004 he moved to Swansea University to act as Chair of Research during the period of early establishment of the School of Medicine and the building of the Institute of Life Science and led the Biomedical Sciences submission in RAE 2008 to a 2.65 score.
Professor Kelly has acted on the International Advisory Board for several conferences and has chaired two international symposia in Swansea in 2005 and 2006. He continues to work closely with industry that has included BP, Shell, GSK, Pfizer, Novartis, Bristol Myers Squibb, Zeneca, Syngenta, BASF, Bayer, Viamet, Mars, Foundation for Water Research and has supervised eleven CASE research studentships. Research in Swansea has been supported by the research councils and FP6. He is Swansea PI on a National Institutes of Health (USA) Programme Grant (2004- ) with M Waterman at Vanderbilt concerning P450 functional genomics in streptomycetes, that was renewed in 2008 and recently obtained a second on antifungal drug resistance with D. Rogers in Memphis. Current interests include molecular microbial research, functional genomics, translational medical microbiology and chemical biology research with over three hundred publications.
- Swansea Science Director
- Member of Swansea Local Management Group
Develop links to:
- exploit microbial use of biomass to produce chemical entities of use to industry and pharma.